Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Potter

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|June 11, 2025
Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: A 20-year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT)Majid Kazmi, Paolo A Muraro, Varun Mehra, et al.
Frontiers in Transplantation|July 12, 2024
Systematic screening and focused evaluation for veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatmentDaniele Avenoso, Michelle Kenyon, Varun Mehra, et al.
Bone Marrow Transplantation|September 16, 2022
Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMTArnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation|September 22, 2022
Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)Eleni Gavriilaki, Myriam Labopin, Ioanna Sakellari, et al.
Bone Marrow Transplantation|January 4, 2026
Outcomes of patients with HTLV-1 adult T-cell leukemia/lymphoma (ATLL) after allogeneic SCT: results of the EBMT LWPPatricia López-Pereira, Ali Bazarbachi, Ambroise Marçais, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2019
Epstein-Barr Virus and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple SclerosisVarun Mehra, Elijah Rhone, Stefani Widya, et al.
Transplantation and Cellular Therapy|August 14, 2023
Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome PatientsDaniele Avenoso, Varun Mehra, Liron Barnea Slonim, et al.
Frontiers in Immunology|January 7, 2022
Corrigendum: Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid LeukemiaJohannes Schetelig, Henning Baldauf, Linda Koster, et al.
Frontiers in Immunology|February 5, 2021
Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid LeukemiaJohannes Schetelig, Henning Baldauf, Linda Koster, et al.
British Journal of Haematology|January 15, 2019
Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survivalAntonio Galleu, Dragana Milojkovic, Simona Deplano, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|June 11, 2025
Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: A 20-year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT)Majid Kazmi, Paolo A Muraro, Varun Mehra, et al.
Frontiers in Transplantation|July 12, 2024
Systematic screening and focused evaluation for veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatmentDaniele Avenoso, Michelle Kenyon, Varun Mehra, et al.
Bone Marrow Transplantation|September 16, 2022
Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMTArnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation|September 22, 2022
Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)Eleni Gavriilaki, Myriam Labopin, Ioanna Sakellari, et al.
Bone Marrow Transplantation|January 4, 2026
Outcomes of patients with HTLV-1 adult T-cell leukemia/lymphoma (ATLL) after allogeneic SCT: results of the EBMT LWPPatricia López-Pereira, Ali Bazarbachi, Ambroise Marçais, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2019
Epstein-Barr Virus and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple SclerosisVarun Mehra, Elijah Rhone, Stefani Widya, et al.
Transplantation and Cellular Therapy|August 14, 2023
Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome PatientsDaniele Avenoso, Varun Mehra, Liron Barnea Slonim, et al.
Frontiers in Immunology|January 7, 2022
Corrigendum: Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid LeukemiaJohannes Schetelig, Henning Baldauf, Linda Koster, et al.
Frontiers in Immunology|February 5, 2021
Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid LeukemiaJohannes Schetelig, Henning Baldauf, Linda Koster, et al.
British Journal of Haematology|January 15, 2019
Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survivalAntonio Galleu, Dragana Milojkovic, Simona Deplano, et al.
Pageof 8